about
Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian populationFactor XIII deficiency in Iran: a comprehensive review of the literature.Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency.Spectrum of factor X gene mutations in Iranian patients with congenital factor X deficiency.Hemophilia in Iran.Diagnosis of factor XIII deficiency.Blood coagulation factor XIII and factor XIII deficiency.Inherited Platelet Function Disorders (IPFDs).Childhood acute lymphoblastic leukemia: refusal and abandonmentof treatment in the southeast of Iran.First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran.Bilineal Acute Leukemia Associated With Fanconi Syndrome: The First Case Report.Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.Inhibition of factor XIIa, a new approach in management of thrombosis.Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.Laboratory Diagnosis of Factor XIII Deficiency in Developing Countries: An Iranian Experience.A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.Congenital combined deficiency of coagulation factors: a study of seven patients.Intracranial hemorrhage in congenital bleeding disorders.Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.Minimal factor XIII activity level to prevent major spontaneous bleeds: comment.Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding Disorders-Prevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency.Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.Guidelines for laboratory diagnosis of factor XIII deficiency.Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran.Molecular genetic analysis of ten unrelated Iranian patients with congenital factor XIII deficiency.Prenatal diagnosis in rare bleeding disorders-An unresolved issue?Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disordersAssociation between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiencyMolecular Basis of Congenital Factor XIII Deficiency in IranA large deletion, spanning exons 1 to 25 of F8 gene, and a high-titer factor VIII inhibitor, in severe hemophilia AHemophilia A in Afghanistan, the first reportA retrospective study on clinical manifestations of neonates with FXIII-A deficiencyHemostasis critical values among Iranian clinical laboratories "National Survey of 157 Clinical Laboratories"Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients
P50
Q30239758-7D13F99F-8957-4DA7-A923-3C195325B549Q36267584-AC68CA56-28D1-4741-98A5-C4A059DBB852Q38329942-8DF0BD41-563C-465C-907D-9B1655625133Q38675846-28A725F3-F643-4C18-AF7C-C89DBF2603A3Q38739422-A283B201-FD88-40AB-A408-71BEF6EABB8AQ38749849-56C4E7DE-A542-41FE-BC6A-6FE587866D89Q38808158-81EB9D69-A104-4915-BA64-2FFC8546956FQ38877203-332B7434-1A29-4279-99DD-39C8AFA98CC9Q39121573-DAB91B9D-67AE-49CA-B7D6-27A35607C82FQ39193204-AA8E4844-DBAD-4FF5-B29A-F40C726C00FCQ39196015-24B5175E-59A8-4DE4-B8B1-7DE355423694Q39492586-44AEB546-3AEF-475D-87EB-326C79BD8490Q39918281-D11D0865-AC43-4319-B888-942EC334A2D3Q40543952-8B2A77C1-112F-4D4D-8A8C-5B865015EB2BQ40699533-0DB815F3-F0A9-40D0-8485-9C70409EF6ADQ40858907-1EF28FA7-DCBC-4507-9A34-0C2FEA248781Q41021592-5441B8CD-5E8B-489F-A891-C148C8765D23Q42355228-39D9093A-6660-46D5-96F9-3432C1CBCF98Q45056724-8D6773D1-7CED-412F-9B62-F4AC57DA90E0Q45242524-8A91C9F4-BFCD-4AC6-B557-666BB6A0CE23Q45859203-045E4DDE-88BB-4614-AB58-93AA966B6C1CQ45868525-6CFC2E28-AF1C-4DC2-9D5A-64BC23DDFBA2Q45871885-79D5F904-8E37-41A1-88B9-D0253DFA3C38Q45882883-5E4B1A44-7B7E-481D-B27C-BD6BB1D41DF0Q47669227-4B2AEED9-8762-4FB9-96DF-E64FC71F88E5Q48130379-8007F46E-EFD6-429C-9E0C-024BF1E16D47Q50131021-DA80D0AE-ABB9-4A97-96FE-07B39456FEF4Q50634086-1BCDE44C-5355-4791-980C-4FA021AA7738Q50769176-243A3D56-CD5F-4A04-A72A-0281C247E97CQ50894760-C948DA99-C4BD-4FA4-865D-61775E51E2BBQ51237228-26A8332A-9DDC-4A03-B059-493F9D4A20E8Q52687460-B3BE64C5-28AC-428C-B316-1AF1EB024DA4Q85669610-F6B5140E-7F16-49D2-A0CF-BF3B6128A4FEQ86415316-390AFADD-9DCB-4DFA-9F1E-853F7F2912E4Q88830577-ECBDEF46-C8E4-4CD8-AB98-C8A20EB384B1Q89995888-CE7948F7-A506-412A-888C-892341388204Q90016749-61050CB7-0CC1-4DA9-BA85-3D78A34C937EQ90041550-69EDCC94-5386-4457-8D7C-5FCB92AFC806Q90327988-8E71C302-D883-429D-82AA-FEF93ADE0719Q90754324-B9039F1C-2E7B-458D-944C-6DA5253A8536
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Akbar Dorgalaleh
@ast
Akbar Dorgalaleh
@en
Akbar Dorgalaleh
@es
Akbar Dorgalaleh
@nl
Akbar Dorgalaleh
@sl
type
label
Akbar Dorgalaleh
@ast
Akbar Dorgalaleh
@en
Akbar Dorgalaleh
@es
Akbar Dorgalaleh
@nl
Akbar Dorgalaleh
@sl
prefLabel
Akbar Dorgalaleh
@ast
Akbar Dorgalaleh
@en
Akbar Dorgalaleh
@es
Akbar Dorgalaleh
@nl
Akbar Dorgalaleh
@sl
P106
P1153
55511552000
P31
P496
0000-0002-0125-9319